Dr. ChoKyun Rha, is a professor of Biomaterial Sciences and Engineering at M.I.T., was the founding and principal investigator for the "Malaysia-MIT Biotechnology Partnership Program", a Malaysian national biotechnology program supported by the Ministry of Science, Technology and Innovation that involved collaborative research, development and training between nineteen Malaysian organizations and M.I.T. that lead to the discovery of LJ100.
A Professor of Biomaterials Sciences and Engineering at the Massachusetts Institute of Technology (M.I.T.), Dr. Rha heads the Biomaterials Science and Engineering Laboratory at the Institute.
Professor Rha's research is aimed at the discovery and engineering of novel biomolecules in a complex systems biology framework and biomaterials for process manufacturing. The focus is on determination of their structure, function and bioactivity. Transcriptional profiling, genomic sequencing and analysis, LC and GC mass spectroscopy, NMR, molecular imaging and micro-rheology are the primary tools for the analysis of the bioactivities of molecules and living systems at the genomic, molecular and cellular level to identify and engineer biosystems to produce valuable natural medicinal and industrial products.
Professor Rha was the founding and principal investigator for the "Malaysia-MIT Biotechnology Partnership Program", a Malaysian national biotechnology program supported by the Ministry of Science, Technology and Innovation that involved collaborative research, development and training between nineteen Malaysian organizations and MIT. Professor Rha has published more than 200 scientific articles and holds over 20 patents. Her research and discoveries have been instrumental in the commercialization and start-up of several biotechnology ventures.
Anthony J. Sinskey, Sc.D. is a Professor of Microbiology and Engineering Systems at M.I.T., and a Professor of Health Sciences and Technology at the Harvard-MIT Division of Health Sciences and Technology, and he has been a member of the faculty at MIT since 1968.
He also holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI). Prof. Sinskey received his undergraduate degree from the University of Illinois at Urbana-Champaign and his Sc.D. in Microbiology and Food Science from the Massachusetts Institute of Technology. Dr. Sinskey is a co-founder and a member of the boards of directors of Metabolix, Inc. and Tepha, Inc. and a consultant to several chemical and biotechnology companies.
Dr. Sinskey holds an Sc.D. from MIT and a B.S. from the University of Illinois, and he was a post-doctoral fellow at the Harvard School of Public Health.
Internationally known as one of the world's leading experts on erectile function. Dr. Lamm is currently the Medical Director of the prestigious Preston Robert Tisch Center for Men's Health at NYU's Langone's Medical Center. He is also an author of The Hardness Factor, and often called the -Doctor-to-the-stars" because of his high-profile celebrity patients and frequent appearances on such TV shows as Dr. Oz, The View, Conan O'Brien and many others. Dr. Lamm did the seminal study on Prelox which is now changing the world of sexual wellness as we know it.
Ralf Henkel currently works at the Department of Medical Biosciences, University of the Western Cape, and Adjunct Senior Scientist at the American Center for Reproductive Medicine at Cleveland Clinic, Cleveland, OH. Ralf does research in Assisted Reproduction, Andrology and Urology. Their current project is 'Investigation of the effect of various indigenous medicinal plants prostate cancer and benign prostatic hyperplasia.
Ralf is also Editor-in-Chief of ANDROLOGIA. Thus far, Ralf published 118 research papers and review articles, 36 book chapters as well as 2 books; his h-index is 34. Ralf does research in Assisted Reproduction, Andrology and Urology with special emphasis on oxidative stress, sperm DNA fragmentation as well as investigating the effects of Traditional Medicine on male reproductive functions including prostate cancer and benign prostatic hyperplasia.
Dr. Cherdshewasart is a Professor in the Department of Biology, on the Faculty of Science at Chulalongkorn University, the first and most famous Thai University. He received his Bachelor of Science in Zoology in 1975, and his Masters in Zoology in 1977. He earned his Masters of Science in Molecular Biology in 1986 and obtained his Doctorate, with great distinction in 1991, at the Vrije University Brussel, Belgium. In 1989 he received the Certificate in Plant Biotechnology by the ICRO-Universitad Complutense de Madrid, Spain.
Mr. Cherdshewasart served as the Chairman of board of Tongkah Harbour Public Co., Ltd. until February 11, 2013. Mr. Cherdshewasart served as an Executive Director of Tongkah Harbour Public Company Limited from February 11, 2013 to June 15, 2017. Mr. Cherdshewasart has been an Independent Director of Tongkah Harbour Public Company Limited. since March 21, 2018. Mr. Cherdshewasart holds B.Sc. in Zoology from Chulalongkorn University; M.Sc. in Zoology from Chulalongkorn University; M.Sc. in Molecular Biology from Institute of Molecular Biolxogy, Free University of Brussels, Belgium; Certificate in Plant Biotechnology from ICRO-Universidad Complutense de Madrid, Spain - D.Sc (Great Distinction) in Molecular Biology from Institute of Molecular Biology, Free University of Brussels, Belgium.